SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-039654
Filing Date
2015-05-20
Accepted
2015-05-20 16:06:59
Documents
7
Period of Report
2015-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-11050_18k.htm 8-K 20074
2 EX-99.1 a15-11050_1ex99d1.htm EX-99.1 85439
3 GRAPHIC g110501mmi001.gif GRAPHIC 49322
4 GRAPHIC g110501mmi002.gif GRAPHIC 57272
5 GRAPHIC g110501mmi003.gif GRAPHIC 42338
6 GRAPHIC g110501mmi004.jpg GRAPHIC 3240
7 GRAPHIC g110501mmi005.jpg GRAPHIC 2092
  Complete submission text file 0001104659-15-039654.txt   319970
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 15879702
SIC: 2834 Pharmaceutical Preparations